You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

herzuma

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Salivary Duct Carcinoma Trial in Seoul (nanoxel, herzuma)

Active, not recruiting
  • Salivary Duct Carcinoma
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Dec 30, 2021

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)

Unknown status
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab biosimilars(Herzuma), Gedatolisib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Breast Cancer, Heart Failure Trial in Canada, Russian Federation (Trastuzumab, Pertuzumab, Trastuzumab emtansine)

Recruiting
  • Breast Cancer
  • Heart Failure
  • Hamitlon, Ontario, Canada
  • +3 more
Jun 21, 2022

HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study Trial (Herzuma)

Not yet recruiting
  • HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
  • Herzuma
  • (no location specified)
Apr 25, 2021

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul (HERZUMA+mFOLFOX)

Recruiting
  • HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Jan 19, 2021

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

HER-2 Positive Gastric Cancer, Metastatic Cancer Trial in Busan (Trastuzumab, Capecitabine, Cisplatin)

Unknown status
  • HER-2 Positive Gastric Cancer
  • Metastatic Cancer
  • Busan, Korea, Republic of
    Dong-A University Hospital
Jul 13, 2018

Endometrial Adenocarcinoma, ERBB2 Gene Amplification, Recurrent Uterine Corpus Carcinoma Trial in Philadelphia (Laboratory

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Trastuzumab
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 30, 2019

Breast Cancer Metastatic, Breast Cancer Female, Breast Cancer Recurrent Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

Completed
  • Breast Cancer Metastatic
  • +2 more
  • Hanoi, Vietnam
  • +1 more
Mar 19, 2022

Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7 Trial in Canada,

Completed
Has Results
  • Bladder Urothelial Carcinoma
  • +3 more
  • Mobile, Alabama
  • +183 more
Jun 28, 2022

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Tucson, Arizona
  • +317 more
Mar 1, 2022

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life

Not yet recruiting
  • HER-2 Positive Breast Cancer
  • Efficacy of the Pertuzumab-Trastuzumab combination
  • Clermont-Ferrand, France
  • +5 more
Nov 20, 2020

Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other,

Completed
  • Breast Adenocarcinoma
  • +6 more
  • Aromatase Inhibition Therapy
  • +6 more
  • Birmingham, Alabama
  • +156 more
Aug 13, 2020

Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)

Active, not recruiting
Has Results
  • Breast Ductal Carcinoma In Situ
  • Laboratory Biomarker Analysis
  • +2 more
  • Anniston, Alabama
  • +1267 more
Jan 28, 2023

HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)

Active, not recruiting
Has Results
  • HER2/Neu Positive
  • +8 more
  • Anniston, Alabama
  • +1291 more
Jan 28, 2023